Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and synovial fluid of osteoarthritic dogs

Veterinary and Comparative Orthopaedics and Traumatology

Volumn 19, Issue 1, 2006, Pages 49-55

  Salinardi, Brenda Jo ^a   Roush, J K ^a   Schermerhorn, T ^a   Mitchell, K E ^b  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

Matrix metalloproteinase; Serum; Synovial fluid

Indexed keywords

CANIS FAMILIARIS;

ALPHA INTERFERON; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; DOG; DOG DISEASE; ENZYMOLOGY; FEMALE; MALE; METABOLISM; OSTEOARTHRITIS; SYNOVIAL FLUID; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FEMALE; INTERFERON-ALPHA; MALE; METALLOPROTEASES; OSTEOARTHRITIS; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 33745009312     PISSN: 09320814     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632973     Document Type: Article

References (32)

1. Aranapakam V, Davis JM, Grosu GT et al. Synthesis and structure - Active relationship of N-substituted 4-arysulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis. J Med Chem 2003; 46; 2376-96.
2. Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: A review. Crit Rev in Oral Biol and Med 1993; 4: 197-250.
3. Byron CR, Orth MW, Venta PJ et al. Influence of glucosamine on matrix metalloproteinase expression and activity in lipopolysaccharide-stimulated equine chondrocytes. Am J Vet Res 2003; 64: 666-71.
4. Catterall JB, Cawston TE. Assay of MMPs and MMP inhibitors: Bioassays and immunoassays applicable to cell culture medium, serum, and synovial fluid. Methods Mol Biol 2003; 225: 353-64.
5. Clark IM, Powell LK, Ramsey S et al. The measurement of collagenase, tissue inhibitor of metalloproteinase (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993; 36: 372-9.
6. Clegg PD, Coughlan AR, Carter SD. Equine TIMP-1 and TIMP-2: identification, activity and cellular sources. Eq Vet J 1998; 30: 416-23.
7. Dean DD, Martel-Pelletier J, Pelletier JP et al. Evidence for metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989; 84: 678-85.
8. Docherty AJ, O'Connell J, Crabbe T et al. The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol 1992; 10: 200-7.
9. Fox DB, Cook JL. Synovial fluid markers of osteoarthritis in dogs. J Am Vet Med Assoc 2001; 219: 756-61.
10. Gamero AM, Earner AC. Vanadate facilitates interferon alpha-mediated apoptosis that is dependent on the Jak/Stat pathway. J Biol Chem 2001; 276: 13547-53.
11. Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000; 43: 1916-26.
12. Hedbom E, Hauselmann HJ. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002; 59: 45-53.
13. Hegemann N, Kohn B, Brunnberg L et al. Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis Cartilage 2002; 10: 714-21.
14. Hegemann N, Wondimu A, Ullrich K et al. Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis. Vet Immunol Immunopathol 2003; 91: 199-204.
15. Johnston SA. Osteoarthritis; Joint anatomy, physiology, and pathobiology. Vet Clin N Am 1997; 27: 699-723.
16. Lee T, Sumpio BE. Cell signalling in vascular cells exposed to cyclic strain: The emerging role of protein phosphatases. Biotechnol Applied Biochem 2004; 39: 129-39.
17. Lohmander LS, Hoerraer LA, Lark MW. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993; 36: 181-9.
18. MacNaul KL, Chartrain N, Lark M et al. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. J Biol Chem 1990; 265: 17238-45.
19. Manicourt DH, Fujimoto N, Obata K et al. Serum levels of collagenase, stromelysin-1, and TIMP-1. Arthritis Rheum 1994; 37: 1774-83.
20. Martel-Pelletier J. Pathophysiology of Osteoarthritis. Osteoarthritis Cartilage 1999; 7: 371-3.
21. Martel-Pelletier J, McCollum R, Fujimoto N et al. Excess of metalloprotease over tissue inhibitor of metalloproteinase may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994; 70: 807-15.
22. Nagase H, Woessner JF. Matrix Metalloproteinases. J Biol Chem 1999; 274: 21491-4.
23. Pelletier JP, Martel-Pelletier J. The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: from molecule to man. Arthritis Res 2002; 4: 13-9.
24. Ray A, Kuroki K, Cook JL et al. Induction of matrix metalloprotein 1 gene expression is regulated by inflammation-responsive transcription factor SAF-1 in osteoarthritis. Arthritis Rheum 2003; 48: 134-45.
25. Romerio F, Riva A, Zella D. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism. Brit J Cancer 2000; 83: 532-8.
26. Rorvik AM, Grondahl AM. Markers of osteoarthritis: A review of the literature. Vet Surg 1995; 24: 255-62.
27. Thyrell L, Hjortsberg L, Arulampalam V et al. Interferon alpha-induced apoptosis in tumour cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signalling pathway. J Biol Chem 2004; 279: 24152-62.
28. Todhunter RJ, Yeager AE, Freeman KP et al. Keratin sulphate as a marker of articular cartilage catabolism and joint treatment in ponies. Am J Vet Res 1993; 54: 1007-6.
29. Torpey N, Maher SE, Bothwell AL et al. Interferon alpha but not interleukin 12 activates STAT4 signalling in human vascular endothelial cells. J Biol Chem 2004; 279: 26789-96.
30. Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -3, -4) in normal and aberrant wound healing. Hum Pathol 1999; 30: 795-802.
31. Volk SW, Kapatkin AS, Haskins ME et al. Gelatinase activity in synovial fluid and synovium obtained from healthy and osteoarthritic joints of dogs. Am J Vet Res 2003; 64: 1225-33.
32. Winyard PG. Inflammation protocols Key stages in the acute inflammatory response and their relevance as therapeutic targets. Methods Mol Biol 2003; 225: 3-5.